Dengue virus NS5 inhibits interferon-α signalling by blocking STAT2 phosphorylation

M Mazzon, M Jones, AD Davidson, B Chain, M Jacobs

Research output: Contribution to journalArticle (Academic Journal)peer-review

154 Citations (Scopus)

Abstract

Type I interferons (interferon [IFN]-α/β) are key mediators of innate antiviral responses. Inhibition of IFN-mediated signal transduction by dengue viruses (DENVs), mosquito-borne flaviviruses of immense global health importance, probably plays a crucial role in determining the outcome of the virus-host interaction. Understanding the molecular basis of IFN antagonism by DENV would therefore provide critical insight into disease pathogenesis and new opportunities for development of antiviral therapies and rationally attenuated vaccines. Here we examine the effects of expression of DENV nonstructural proteins on cellular IFN responses. We show that expression of nonstructural protein 5 (NS5) alone inhibits IFN-α, but not IFN-γ, signaling. Expression of the polymerase domain of NS5 is sufficient to inhibit IFN-α signaling. NS5 binds signal transducer and activator of transcription 2 (STAT2) and inhibits its phosphorylation. NS5 alone did not, however, induce degradation of STAT2, which occurs when all nonstructural proteins are expressed together. We conclude that DENV NS5 is a potent and specific type I IFN antagonist.
Translated title of the contributionDengue virus NS5 inhibits interferon-α signalling by blocking STAT2 phosphorylation
Original languageEnglish
Pages (from-to)1261 - 1270
Number of pages10
JournalJournal of Infectious Diseases
Volume200
Issue number8
DOIs
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'Dengue virus NS5 inhibits interferon-α signalling by blocking STAT2 phosphorylation'. Together they form a unique fingerprint.

Cite this